This comes after the board identified the practical issues and restrictions imposed on international travel during the COVID-19 pandemic, which affect the ability of directors to travel between Australia, the USA and other countries.
Having an additional Sydney-based director will assist CardieX to be more responsive to the local business’ needs and requirements and will enhance the board’s capacity as the company grows its presence, product range and revenue internationally in the coming months and years.
Appointment strengthens board
White has been the chief financial officer and company secretary of CardieX since early 2018.
While continuing in both roles, with Philip Leighfield’s appointment as joint company secretary, White’s appointment as a director is also recognition of this significant contribution over the last two years.
CardieX chairman Niall Cairns said: “This is a sensible appointment by the board particularly during the current economic climate and Jarrod’s credentials as an experienced Chartered Accountant will strengthen the board’s capacity during a time of growth and change for the company.”
Substantial holder interest changes
Meantime, substantial holder Paul Cozzi has increased his stake in the company to 14.58% from 12.96% with the change occurring on May 7.
On that date, Sydney-based Cozzi acquired 11.9 million shares valued at approximately $250,000 and he now holds more than 109.5 million shares.